TWI610694B - Dressing composition - Google Patents

Dressing composition Download PDF

Info

Publication number
TWI610694B
TWI610694B TW105139554A TW105139554A TWI610694B TW I610694 B TWI610694 B TW I610694B TW 105139554 A TW105139554 A TW 105139554A TW 105139554 A TW105139554 A TW 105139554A TW I610694 B TWI610694 B TW I610694B
Authority
TW
Taiwan
Prior art keywords
wound dressing
dressing composition
molecule
wound
weight
Prior art date
Application number
TW105139554A
Other languages
Chinese (zh)
Other versions
TW201821114A (en
Inventor
謝蘋怡
林志隆
張志豪
Original Assignee
財團法人金屬工業研究發展中心
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 財團法人金屬工業研究發展中心 filed Critical 財團法人金屬工業研究發展中心
Priority to TW105139554A priority Critical patent/TWI610694B/en
Application granted granted Critical
Publication of TWI610694B publication Critical patent/TWI610694B/en
Publication of TW201821114A publication Critical patent/TW201821114A/en

Links

Landscapes

  • Materials For Medical Uses (AREA)

Abstract

一種傷口敷料組合物,係用以於傷口表面成形一薄膜層,其包含:以重量百分比計為55~73%之一基材、17~35%之一吸水材及2~6%之一感濕變色分子。 A wound dressing composition for forming a film layer on a surface of a wound, comprising: 55 to 73% by weight of a substrate, 17 to 35% of a water absorbing material, and 2 to 6% of a feeling Wet color changing molecules.

Description

傷口敷料組合物 Wound dressing composition

本發明係關於一種傷口敷料組合物,特別關於一種具有警示更換時機的傷口敷料組合物。 This invention relates to a wound dressing composition, and more particularly to a wound dressing composition having a warning replacement timing.

對於皮膚所受的擦傷、割傷、燒傷等傷口的處理,一般可以於傷口上覆蓋一習用傷口敷料,以避免傷口直接暴露於空氣中。 For the treatment of wounds such as abrasions, cuts, burns and the like on the skin, it is generally possible to cover a wound dressing with a conventional wound dressing to prevent the wound from being directly exposed to the air.

當該習用傷口敷料吸收過多的滲液,卻沒有適時地更換時,反而可能會導致傷口的再感染,因此該習用傷口敷料的適時更換對於傷口的癒合極為重要。 When the conventional wound dressing absorbs too much exudate but does not replace it in a timely manner, it may cause reinfection of the wound, so timely replacement of the conventional wound dressing is extremely important for wound healing.

使用者雖然能夠藉由該習用傷口敷料吸收滲液(如組織液、血液等),當該習用傷口敷料所吸收之滲液達到一定量後,該習用傷口敷料即無法繼續吸收滲液,此時滲液可能會自該習用傷口敷料與傷口之間滲出,使用者即可以藉此評估該習用傷口敷料的替換時機。但針對覆蓋於使用者較不容易看見的傷口表面的習用傷口敷料,不僅傷者本人不容易觀察到滲液外流的狀況,導致醫護人員容易忽略該習用傷口敷料的更換,而可能造成傷口重複感染的嚴重後果。有鑑於此,習用傷口敷料確實仍有加以改善之必要。 Although the user can absorb the exudate (such as tissue fluid, blood, etc.) by the conventional wound dressing, the conventional wound dressing can not continue to absorb the exudate when the exudate absorbed by the conventional wound dressing reaches a certain amount. The fluid may ooze from the conventional wound dressing to the wound, and the user can thereby assess the timing of replacement of the conventional wound dressing. However, for the conventional wound dressing which covers the surface of the wound which is less visible to the user, it is not only easy for the injured person to observe the condition of the exudate outflow, so that the medical staff can easily neglect the replacement of the conventional wound dressing, which may cause repeated infection of the wound. Serious consequences. In view of this, the conventional wound dressings still have the need to improve.

為解決上述問題,本發明係提供一種傷口敷料組合物,有利於使用者評估更換覆蓋於傷口表面之傷口敷料組合物的時機者。 In order to solve the above problems, the present invention provides a wound dressing composition which is useful for a user to evaluate the timing of replacing a wound dressing composition covering a wound surface.

本發明之一種傷口敷料組合物,係包含:以重量百分比計為 55~73%之一基材、17~35%之一吸水材及2~6%之一感濕變色分子,該感濕變色分子包含以重量百分比計為85%之聚乙二醇、10%之吸濕分子及5%之呈色分子。如此,本發明之傷口敷料組合物藉由該基材可以穩固貼覆於傷口表面,以避免傷口直接暴露於空氣,並藉由該吸水材吸收滲液,使該傷口敷料組合物可以使傷口維持濕潤的狀態,更藉由該感濕變色分子感知該滲液的多寡而呈現顏色,進而可以讓使用者清楚瞭解該傷口敷料組合物更換的時機,為本發明之功效。 A wound dressing composition of the present invention comprising: 55 to 73% of one substrate, 17 to 35% of one water absorbing material, and 2 to 6% of one of the moisture sensitive color molecules, the moisture sensitive color molecule containing 85% by weight of polyethylene glycol, 10% The hygroscopic molecule and 5% of the coloring molecules. Thus, the wound dressing composition of the present invention can be stably applied to the surface of the wound by the substrate to prevent the wound from being directly exposed to the air, and the exudate is absorbed by the absorbent material, so that the wound dressing composition can maintain the wound. In the wet state, the color of the exudate is perceived by the moist-staining color molecule, and the user can clearly understand the timing of the replacement of the wound dressing composition, which is the effect of the present invention.

本發明之傷口敷料組合物,其中,該吸濕分子為氧化鈣,該呈色分子為酚酞或薑黃素;較佳地,聚乙二醇包含分子量為400、700及1000之聚乙二醇,且分子量為400、700及1000之聚乙二醇係以等重量比混合。如此,氧化鈣可以與該吸水材所吸收的水分反應而形成氫氧化鈣而釋放氫氧離子,氫氧離子再跟酚酞反應後,使酚酞自無色的內酯式結構轉變為紅色的醌式結構;或者,氧化鈣所釋放之氫氧離子再跟薑黃素反應而使該感濕變色分子自黃色轉變為紅色,因而可以使該傷口敷料組合物呈現使用者可以容易看見的紅色。 The wound dressing composition of the present invention, wherein the hygroscopic molecule is calcium oxide, and the coloring molecule is phenolphthalein or curcumin; preferably, the polyethylene glycol comprises polyethylene glycol having molecular weights of 400, 700 and 1000, Polyethylene glycol having a molecular weight of 400, 700 and 1000 is mixed in an equal weight ratio. Thus, the calcium oxide reacts with the moisture absorbed by the water absorbing material to form calcium hydroxide to release hydroxide ions, and the hydroxide ions react with the phenolphthalein to convert the phenolphthalein from a colorless lactone structure to a red quinoid structure. Alternatively, the hydroxide ions released by the calcium oxide react with curcumin to convert the hygroscopic color-changing molecule from yellow to red, thereby allowing the wound dressing composition to exhibit a red color that is easily visible to the user.

本發明之傷口敷料組合物,其中,該基材為矽凝膠;舉例而言,該基材包含以重量百分比計為60%之聚山梨醇酯、30%之矽樹脂共聚物、8%之聚二甲基矽氧烷及2%之交聯聚二甲基矽氧烷,於本實施例中,該基材係由包含以下步驟之方法所得:將矽樹脂共聚物均勻分散於聚二甲基矽氧烷中,以獲得一分散液;將聚山梨醇酯及交聯聚二甲基矽氧烷依序加入該分散液中,以獲得一待成形溶液;及於60℃下加熱攪拌該待成形溶液,並於室溫下冷卻。如此,藉由矽凝膠的高延展性、高服貼性、高親和性及不容易沾黏等特點,使該傷口敷料組合物可以穩固貼覆於傷口表面。 The wound dressing composition of the present invention, wherein the substrate is a ruthenium gel; for example, the substrate comprises 60% by weight of polysorbate, 30% of ruthenium resin copolymer, 8% Polydimethyl methoxy oxane and 2% cross-linked polydimethyl methoxy oxane. In this embodiment, the substrate is obtained by a method comprising the steps of: uniformly dispersing a ruthenium resin copolymer in polydimethylene a sulfoxide to obtain a dispersion; a polysorbate and a cross-linked polydimethyl siloxane are sequentially added to the dispersion to obtain a solution to be formed; and the mixture is heated and stirred at 60 ° C. The solution to be formed was cooled at room temperature. Thus, the wound dressing composition can be stably applied to the wound surface by the high ductility, high conformability, high affinity and non-stickiness of the gel.

本發明之傷口敷料組合物,其中,該吸水材為羧甲基纖維素。如此,藉由羧甲基纖維素能夠吸收水分,並進而將水分保留於該傷口 敷料組合物之中,因而該傷口敷料組合物於傷口表面形成薄膜層時,該薄膜層可以使傷口保持濕潤的狀態,而具有促進傷口癒合的效果。 The wound dressing composition of the present invention, wherein the water absorbing material is carboxymethyl cellulose. Thus, carboxymethylcellulose is capable of absorbing moisture and thereby retaining moisture in the wound. Among the dressing compositions, and thus the wound dressing composition forms a film layer on the wound surface, the film layer maintains the wound in a wet state and has an effect of promoting wound healing.

本發明之傷口敷料組合物,其中,該傷口敷料組合物包含以重量百分比計為8~25%之一微生物指示劑;較佳地,該微生物指示劑為可以專一性偵測微生物的探針。如此,藉由該微生物指示劑偵測微生物的存在,令使用者可以據此評估傷口是否發生感染。 The wound dressing composition of the present invention, wherein the wound dressing composition comprises from 8 to 25% by weight of one of the microbial indicators; preferably, the microbial indicator is a probe capable of specifically detecting microorganisms. Thus, by detecting the presence of the microorganism by the microbial indicator, the user can thereby assess whether the wound is infected.

〔本發明〕 〔this invention〕

1‧‧‧傷口敷料組合物 1‧‧‧Wound dressing composition

11‧‧‧基材 11‧‧‧Substrate

12‧‧‧吸水材 12‧‧‧Water absorption material

13‧‧‧感濕變色分子 13‧‧‧Damp-staining molecules

14‧‧‧微生物指示劑 14‧‧‧Microbial indicator

W‧‧‧傷口表面 W‧‧‧Wound surface

第1圖:本發明之第一、第二實施例的傷口敷料組合物於傷口表面所形成之薄膜層的示意圖。 Fig. 1 is a schematic view showing a film layer formed on the wound surface by the wound dressing composition of the first and second embodiments of the present invention.

第2圖:本發明之第三實施例的傷口敷料組合物於傷口表面所形成之薄膜層的示意圖。 Fig. 2 is a schematic view showing a film layer formed on the wound surface by the wound dressing composition of the third embodiment of the present invention.

為讓本發明之上述及其他目的、特徵及優點能更明顯易懂,下文特舉本發明之較佳實施例,並配合所附圖式,作詳細說明如下:請參照第1圖所示,本發明之一實施例中,該傷口敷料組合物1可以包含:一基材11、一吸水材12及一感濕變色分子13,因而當該傷口敷料組合物1塗佈於傷口表面時,可以於傷口表面W形成完整覆蓋傷口之薄膜層,並藉由該吸水材12吸收滲液,而該感濕變色分子13則可以感知該滲液的多寡而呈現顏色,進而可以有助於使用者適時更換該傷口敷料組合物1所形成之薄膜層。 The above and other objects, features, and advantages of the present invention will become more apparent from the aspects of the appended claims. In one embodiment of the present invention, the wound dressing composition 1 may include: a substrate 11, a water absorbing material 12, and a moisture sensitive coloring molecule 13, so that when the wound dressing composition 1 is applied to the wound surface, Forming a film layer covering the wound completely on the wound surface W, and absorbing the exudate by the water absorbing material 12, and the sensible color changing molecule 13 can sense the amount of the oozing liquid and present a color, thereby facilitating the user's timelyness. The film layer formed by the wound dressing composition 1 is replaced.

詳而言之,該傷口敷料組合物1可以包含以重量百分比計為55~73%之基材11,舉例而言,該基材11可以為矽凝膠(silica gel),以藉由矽凝膠的高延展性、高服貼性、高親和性及不容易殘留膠體於傷口表面W等特點,而可以使該傷口敷料組合物1穩固貼覆於傷口表面W。 In detail, the wound dressing composition 1 may comprise 55 to 73% by weight of the substrate 11 . For example, the substrate 11 may be a silica gel to be coagulated by ruthenium. The high flexibility of the glue, high conformability, high affinity and the tendency to leave the colloid on the wound surface W, and the wound dressing composition 1 can be firmly applied to the wound surface W.

於本實施例中,該基材11可以包含以重量百分比計為60%之聚山梨醇酯、30%之聚矽氧烷-11(polysilicone-11)、8%之聚二甲基矽氧烷(polydimethylsiloxane,又稱矽油)及2%之交聯聚二甲基矽氧烷(cross-linked polydimethylsiloxane);例如可以由包含以下步驟之方法所得:將該聚矽氧烷-11均勻分散於聚二甲基矽氧烷中,以獲得一分散液;將聚山梨醇酯及交聯聚二甲基矽氧烷(特別為粉末型態)依序加入該分散液中,以獲得一待成形溶液;及於60℃下加熱攪拌該待成形溶液2小時,並於室溫下冷卻,使該待成形溶液成為凝膠態,即可以獲得該基材11。 In this embodiment, the substrate 11 may comprise 60% by weight of polysorbate, 30% of polysilicone-11, and 8% of polydimethyloxane. (polydimethylsiloxane, also known as eucalyptus oil) and 2% cross-linked polydimethylsiloxane; for example, it can be obtained by a method comprising the steps of: uniformly dispersing the polyoxyalkylene-11 in poly In a methyl oxane, a dispersion is obtained; a polysorbate and a cross-linked polydimethyl siloxane (particularly in a powder form) are sequentially added to the dispersion to obtain a solution to be formed; And the solution to be formed is heated and stirred at 60 ° C for 2 hours, and cooled at room temperature to make the solution to be formed into a gel state, that is, the substrate 11 can be obtained.

又,該傷口敷料組合物1可以包含以重量百分比計為17~35%之吸水材12,舉例而言,該吸水材12可以為羧甲基纖維素(carboxymethyl cellulose,簡稱CMC),藉由羧甲基纖維素而能夠確實吸收傷口分泌之滲液(如組織液、血液等)。特別的是,羧甲基纖維素能夠以細小粉末之型態添加於該基材11中,藉此於該傷口敷料1以凝膠態樣塗覆於該傷口表面W而形成該薄膜層時,羧甲基纖維素能夠發揮較佳吸收滲液之功效,同時亦可避免材料產生生物毒性的不良影響。 Further, the wound dressing composition 1 may comprise 17 to 35% by weight of the water absorbing material 12, for example, the water absorbing material 12 may be carboxymethyl cellulose (CMC), by carboxy Methylcellulose can indeed absorb exudates (such as tissue fluid, blood, etc.) secreted by the wound. In particular, carboxymethylcellulose can be added to the substrate 11 in the form of a fine powder, whereby when the wound dressing 1 is applied to the wound surface W in a gel form to form the film layer, Carboxymethylcellulose can exert the effect of better absorption of exudates, while also avoiding the adverse effects of biotoxicity of materials.

接著,該傷口敷料組合物1還可以包含以重量百分比計為2~6%之感濕變色分子13。詳而言之,該感濕變色分子13可以包含一吸濕分子及一呈色分子,且該吸濕分子能夠與該吸水材所吸收的水分反應,進而使該呈色分子發生顏色的改變;舉例而言,第一實施例中,該吸濕分子為氧化鈣(calcium oxide),該呈色分子為酚酞(phenolphthalein),如此,氧化鈣可以與該吸水材12所吸收的水分反應而形成氫氧化鈣(calcium hydroxide),氫氧化鈣可以進一步釋放氫氧離子(hydroxide ion),氫氧離子再跟酚酞反應後,使酚酞自無色的內酯式結構(lactone form)轉變為紅色的醌式結構(phenolate form),因而可以使該傷口敷料組合物1呈現使用者可以容易看見的紅色;又,於第二實施例中,該呈色分子則可以為薑 黃素(curcumin),如此,氧化鈣經作用所生成之氫氧離子可以跟薑黃素反應,而使該薑黃素自黃色轉變為紅色的苯氧(酚)自由基(curcumin phenoxyl radicals)結構,且因薑黃素的生物毒性低於酚酞更適合作為本實施例之呈色分子,以降低生物毒性對人體的傷害。 Next, the wound dressing composition 1 may further comprise 2 to 6% by weight percent of the hygroscopic discoloring molecule 13. In detail, the hygroscopic color-changing molecule 13 may comprise a hygroscopic molecule and a color-developing molecule, and the hygroscopic molecule is capable of reacting with the moisture absorbed by the water-absorbing material, thereby causing a color change of the color-developing molecule; For example, in the first embodiment, the moisture absorbing molecule is calcium oxide, and the coloring molecule is phenolphthalein. Thus, the calcium oxide can react with the water absorbed by the water absorbing material 12 to form hydrogen. Calcium hydroxide, calcium hydroxide can further release hydroxide ions, which react with phenolphthalein to convert phenolphthalein from a colorless lactone form to a red quinone structure. (phenolate form), so that the wound dressing composition 1 can be made red which can be easily seen by a user; in addition, in the second embodiment, the colored molecule can be ginger Curcumin, as such, the hydroxide ions formed by the action of calcium oxide can react with curcumin to convert the curcumin from yellow to red curcumin phenoxyl radicals, and Because curcumin is less toxic than phenolphthalein, it is more suitable as a coloring molecule in this embodiment to reduce the harm of biological toxicity to the human body.

此外,為了提升該感濕變色分子13與該吸水材12的混合均勻度及進一步修飾該吸濕分子如氧化鈣所帶有的毒性官能基,該感濕變色分子13可以另包含聚乙二醇(polyethylene glycol),例如分子量為400、700及1000之聚乙二醇及其組合。本實施例中,該感濕變色分子13包含以重量百分比為80~90%之聚乙二醇(polyethylene glycol)、5~15%之吸濕分子及2~8%的呈色分子,且分子量為400、700及1000之聚乙二醇係以等重量比混合。 Further, in order to enhance the mixing uniformity of the hygroscopic color-changing molecule 13 and the water-absorbing material 12 and further modify the toxic functional group carried by the moisture-absorbing molecule such as calcium oxide, the hygroscopic color-changing molecule 13 may further comprise polyethylene glycol. (polyethylene glycol), such as polyethylene glycol having a molecular weight of 400, 700 and 1000, and combinations thereof. In the present embodiment, the moisture-sensitive color-changing molecule 13 comprises polyethylene glycol (polyethylene glycol) in an amount of 80-90% by weight, hygroscopic molecules of 5 to 15%, and color molecules of 2 to 8%, and molecular weight. Polyethylene glycols of 400, 700 and 1000 are mixed in equal weight ratios.

如此,使用者可以將該傷口敷料組合物1塗佈於傷口表面W,使該傷口敷料組合物1可以形成該薄膜層,該傷口敷料組合物1之吸水材12可以吸收滲液中的水分,當該吸水材12吸收足量的水分後,即會使得該傷口敷料組合物1之感濕變色分子13產生顏色的變化,使該薄膜層呈現紅色,此時使用者即可以適時更換該傷口敷料組合物1所形成之薄膜層,以避免滲液過多造成的感染等問題。 Thus, the user can apply the wound dressing composition 1 to the wound surface W, so that the wound dressing composition 1 can form the film layer, and the water absorbing material 12 of the wound dressing composition 1 can absorb moisture in the liquid. When the water absorbing material 12 absorbs a sufficient amount of moisture, the color change of the sensible color changing molecule 13 of the wound dressing composition 1 is caused to make the film layer appear red, and the user can replace the wound dressing at a timely time. The film layer formed by the composition 1 is used to avoid problems such as infection caused by excessive bleeding.

此外,續請參照第2圖所示,於本發明的第三實施例中,該傷口敷料組合物1可以另包含以重量百分比計為8~25%之一微生物指示劑14,該微生物指示劑14可以為微生物的標定體,舉例而言,可以於一纖維試片上標定微生物所能產生之酵素的受質,並將該纖維試片裁剪成適當大小後添加於該傷口敷料1中。詳言之,當該傷口敷料組合物1所吸收的滲液中含有微生物時,微生物產生之酵素即可以對該受質進行專一性的酶轉換作用,而於該傷口敷料組合物1中形成有色菌落。於本實施例中,係可以於該纖維試片上標定吡喃葡萄糖苷(glucopyranose)作為受質,當 微生物所產生之β-葡萄糖苷酶(β-glucosidase)對該受質進行專一性的酶轉換作用,即可以形成藍色菌落,藉以發現是否有微生物感染,即時替患者的傷口進行該傷口敷料1的替換。 In addition, as shown in FIG. 2, in the third embodiment of the present invention, the wound dressing composition 1 may further comprise 8 to 25% by weight of one of the microbial indicators 14, the microbial indicator. 14 may be a calibration body of a microorganism. For example, the substrate of the enzyme which can be produced by the microorganism can be calibrated on a fiber test piece, and the fiber test piece is cut into an appropriate size and added to the wound dressing 1. In particular, when the exudate absorbed by the wound dressing composition 1 contains a microorganism, the enzyme produced by the microorganism can perform a specific enzymatic conversion of the substance, and a colored color is formed in the wound dressing composition 1. Colonies. In this embodiment, glucopyranose can be labeled as a substrate on the fiber test piece. The β-glucosidase produced by the microorganism specifically converts the substrate to form a blue colony, thereby finding out whether there is a microbial infection, and immediately performing the wound dressing for the wound of the patient 1 Replacement.

因此,於本發明之第二實施例中,使用者除了可以藉由該傷口敷料組合物1之感濕變色分子13的顏色變化,來得知該傷口敷料組合物1所吸收的滲液多寡外,更可以利用該微生物指示劑14所釋放出的訊號,來得知滲液當中是否有特定微生物的存在,因而使用者可以據此評估傷口是否已經滋生特定微生物。 Therefore, in the second embodiment of the present invention, the user can know the amount of exudate absorbed by the wound dressing composition 1 by the color change of the hygroscopic discoloring molecule 13 of the wound dressing composition 1. The signal released by the microbial indicator 14 can be used to know whether there is a specific microorganism in the exudate, so that the user can evaluate whether the wound has already raised a specific microorganism.

綜合上述,本發明之傷口敷料組合物1藉由該基材11可以穩固貼覆於傷口表面W,以避免傷口直接暴露於空氣,並藉由該吸水材12吸收滲液且搭配該感濕變色分子13感知該滲液的多寡而呈現顏色,進而可以讓使用者清楚瞭解該傷口敷料組合物1更換的時機,為本發明之功效。 In summary, the wound dressing composition 1 of the present invention can be stably applied to the wound surface W by the substrate 11 to prevent the wound from being directly exposed to the air, and absorb the exudate by the water absorbing material 12 and match the moist color change. The molecule 13 senses the amount of the exudate and presents a color, which in turn allows the user to clearly understand the timing of the replacement of the wound dressing composition 1, which is an effect of the present invention.

再者,由於本發明之傷口敷料組合物1另藉由該微生物指示劑14偵測特定微生物的存在,令使用者可以據此評估傷口是否滋生特定微生物,為本發明之功效。 Furthermore, since the wound dressing composition 1 of the present invention detects the presence of a specific microorganism by the microbial indicator 14, the user can thereby evaluate whether the wound breeds a specific microorganism, which is an effect of the present invention.

雖然本發明已利用上述較佳實施例揭示,然其並非用以限定本發明,任何熟習此技藝者在不脫離本發明之精神和範圍之內,相對上述實施例進行各種更動與修改仍屬本發明所保護之技術範疇,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。 While the invention has been described in connection with the preferred embodiments described above, it is not intended to limit the scope of the invention. The technical scope of the invention is protected, and therefore the scope of the invention is defined by the scope of the appended claims.

1‧‧‧傷口敷料組合物 1‧‧‧Wound dressing composition

11‧‧‧基材 11‧‧‧Substrate

12‧‧‧吸水材 12‧‧‧Water absorption material

13‧‧‧感濕變色分子 13‧‧‧Damp-staining molecules

W‧‧‧傷口表面 W‧‧‧Wound surface

Claims (11)

一種傷口敷料組合物,係包含:以重量百分比計為55~73%之一基材、17~35%之一吸水材及2~6%之一感濕變色分子,且該感濕變色分子包含以重量百分比計為85%之聚乙二醇、10%之吸濕分子及5%之呈色分子。 A wound dressing composition comprising: 55 to 73% by weight of a substrate, 17 to 35% of a water absorbing material, and 2 to 6% of one of the moisture sensitive color molecules, and the moisture sensitive color molecule comprises 85% by weight of polyethylene glycol, 10% of hygroscopic molecules and 5% of colored molecules. 如申請專利範圍第1項所述之傷口敷料組合物,其中,該吸濕分子為氧化鈣,該呈色分子為酚酞。 The wound dressing composition of claim 1, wherein the hygroscopic molecule is calcium oxide and the coloring molecule is phenolphthalein. 如申請專利範圍第1項所述之傷口敷料組合物,其中,該吸濕分子為氧化鈣,該呈色分子為薑黃素。 The wound dressing composition of claim 1, wherein the hygroscopic molecule is calcium oxide and the coloring molecule is curcumin. 如申請專利範圍第1項所述之傷口敷料組合物,其中,聚乙二醇包含分子量為400、700及1000之聚乙二醇。 The wound dressing composition of claim 1, wherein the polyethylene glycol comprises polyethylene glycol having a molecular weight of 400, 700 and 1000. 如申請專利範圍第4項所述之傷口敷料組合物,其中,分子量為400、700及1000之聚乙二醇係以等重量比混合。 The wound dressing composition of claim 4, wherein the polyethylene glycol having a molecular weight of 400, 700 and 1000 is mixed in an equal weight ratio. 如申請專利範圍第1項所述之傷口敷料組合物,其中,該基材為矽凝膠。 The wound dressing composition of claim 1, wherein the substrate is a ruthenium gel. 如申請專利範圍第6項所述之傷口敷料組合物,其中,該基材包含以重量百分比計為60%之聚山梨醇酯、30%之聚矽氧烷-11、8%之聚二甲基矽氧烷及2%之交聯聚二甲基矽氧烷。 The wound dressing composition of claim 6, wherein the substrate comprises 60% by weight of polysorbate, 30% of polyoxyalkylene-11, and 8% of polydimethylene. Alkoxyoxane and 2% crosslinked polydimethyloxane. 如申請專利範圍第7項所述之傷口敷料組合物,其中,該基材係由包含以下步驟之方法所得:將聚矽氧烷-11均勻分散於聚二甲基矽氧烷中,以獲得一分散液;將聚山梨醇酯及交聯聚二甲基矽氧烷依序加入該分散液中,以獲得一待成形溶液;及於60℃下加熱攪拌該待成形溶液,並於室溫下冷卻。 The wound dressing composition according to claim 7, wherein the substrate is obtained by a method comprising the steps of: uniformly dispersing polyoxyalkylene-11 in polydimethyl siloxane to obtain a dispersion; a polysorbate and a cross-linked polydimethyl siloxane are sequentially added to the dispersion to obtain a solution to be formed; and the solution to be formed is heated and stirred at 60 ° C, and at room temperature Cool down. 如申請專利範圍第1項所述之傷口敷料組合物,其中,該吸水材為羧甲基纖維素。 The wound dressing composition of claim 1, wherein the water absorbing material is carboxymethyl cellulose. 如申請專利範圍第1項所述之傷口敷料組合物,其中,該傷口敷料組合物包含以重量百分比計為8~25%之一微生物指示劑。 The wound dressing composition of claim 1, wherein the wound dressing composition comprises from 8 to 25% by weight of the microbial indicator. 如申請專利範圍第10項所述之傷口敷料組合物,其中,該微生物指示劑為可以專一性偵測微生物的標定體。 The wound dressing composition of claim 10, wherein the microbial indicator is a calibrator capable of specifically detecting microorganisms.
TW105139554A 2016-11-30 2016-11-30 Dressing composition TWI610694B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW105139554A TWI610694B (en) 2016-11-30 2016-11-30 Dressing composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW105139554A TWI610694B (en) 2016-11-30 2016-11-30 Dressing composition

Publications (2)

Publication Number Publication Date
TWI610694B true TWI610694B (en) 2018-01-11
TW201821114A TW201821114A (en) 2018-06-16

Family

ID=61728591

Family Applications (1)

Application Number Title Priority Date Filing Date
TW105139554A TWI610694B (en) 2016-11-30 2016-11-30 Dressing composition

Country Status (1)

Country Link
TW (1) TWI610694B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040191118A1 (en) * 2003-03-24 2004-09-30 Nita Mody Wetness indicator
CN103118712A (en) * 2010-09-17 2013-05-22 3M创新有限公司 Antimicrobial disposable absorbent articles
CN105999366A (en) * 2016-07-28 2016-10-12 广东泰宝医疗科技股份有限公司 Preparation method of color-developing medical dressing

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040191118A1 (en) * 2003-03-24 2004-09-30 Nita Mody Wetness indicator
CN103118712A (en) * 2010-09-17 2013-05-22 3M创新有限公司 Antimicrobial disposable absorbent articles
CN105999366A (en) * 2016-07-28 2016-10-12 广东泰宝医疗科技股份有限公司 Preparation method of color-developing medical dressing

Also Published As

Publication number Publication date
TW201821114A (en) 2018-06-16

Similar Documents

Publication Publication Date Title
CN1805761B (en) Elastomer-forming barrier preparation
ES2552693T3 (en) Foam dressing comprising an antimicrobial silver
ES2200004T3 (en) SPIROSORBENT BANDS OF WOUNDS FOR REGULATION OF EXUDATES.
JP5270158B2 (en) Adhesive composition
WO2009107189A1 (en) Wound-covering hydrogel material
KR100859339B1 (en) Silicon composition for dressing, the dressing and the method for manufacturing it
CN103463669A (en) Liquid wound dressing and preparation method thereof
AU2018369903A1 (en) Buffered adhesive compositions for skin-adhering medical products
BR112014005437B1 (en) SENSOR AND ABSORBENT ARTICLE
US20110218472A1 (en) Non drug based wound dressing polymer film and a method of producing the same
KR101763368B1 (en) Silicon adhesvie compositoin with hyaluronic acid for moisturizing skin
JP6170171B2 (en) Water display hydrophilic polyurethane
BRPI0711424B1 (en) pressure sensitive adhesive composition, pressure sensitive adhesive, and medical device
EP3182946B1 (en) Buffered adhesive compositions for skin-adhering medical products
BR102012012026A2 (en) CURATIVE II
KR20090086597A (en) Skin coating with microbial indicator
CN115666666A (en) Novel antimicrobial topical skin closure compositions and systems
JPS63153068A (en) Adhesive article
TWI610694B (en) Dressing composition
KR101539675B1 (en) Hydrogel patch for wound healing and monitoring
JP2008073287A (en) Hydrogel wound covering material
TW202102273A (en) A breathable and waterproof of moist dressings
JP2637672B2 (en) Composition for wound dressing
JP2012107120A (en) Adhesive gel
CN201684082U (en) Self-adhesive chitosan-based compound homeostatic healing-promotion sponge